M11.13
Familial chondrocalcinosis, wrist
Clinical Classification Guidelines
Medical Intelligence & Overview
Familial chondrocalcinosis, also known as calcium pyrophosphate dihydrate (CPPD) crystal deposition disease, affects the cartilage within joints, leading to its calcification. When this condition occurs specifically in the wrist, it can cause significant discomfort and mobility issues. The familial aspect indicates a genetic predisposition, meaning it often runs in families. Recognizing this condition is crucial for managing symptoms and preventing joint damage over time.
Causes & Symptoms
Clinical Causes: Genetic factors: Inherited genes increase susceptibility to calcium crystal deposition in cartilage. Age: The risk rises with advancing age, as cartilage becomes more prone to degeneration and mineralization. Metabolic disorders: Conditions such as hyperparathyroidism, hemochromatosis, and hypothyroidism can contribute to calcium crystal formation. Previous joint injuries: Traumatic injuries to the wrist may predispose to crystal deposits during healing or degeneration. Environmental factors: Lifestyle factors like diet and exposure to toxins may play a minor role in disease development.
Key Symptoms: Joint pain: Typically described as aching or throbbing, often exacerbated by movement or pressure. Swelling: The wrist may become swollen due to inflammation caused by crystal deposits. Stiffness: Reduced range of motion in the affected wrist can occur, impacting daily activities. Tenderness: The joint may be tender to touch, especially during flare-ups. Warmth: The affected area might feel warm, indicating inflammation. Recurring attacks: Symptoms can come and go, with periods of remission.
Diagnostic & Treatment
Diagnosis Path: X-rays: These are the primary imaging modality used to visualize calcification within the wrist cartilage. Ultrasound: Can detect crystal deposits and joint effusion. Joint aspiration: A sample of synovial fluid is extracted and examined under a microscope to identify calcium pyrophosphate crystals. Blood tests: Used to rule out other conditions and check for metabolic disorders that may contribute to disease development.
Treatment Protocols: Medications: Nonsteroidal anti-inflammatory drugs (NSAIDs) for pain and inflammation, colchicine to prevent flare-ups, and corticosteroids in severe cases. Physical therapy: Exercises to improve joint mobility and strengthen supporting muscles. Lifestyle modifications: Maintaining a healthy weight, avoiding activities that stress the wrist, and ensuring adequate rest during flare-ups. Monitoring and managing metabolic disorders: Addressing any underlying health issues that may contribute to calcium crystal formation. Surgical intervention: Rarely, if joint damage is severe, procedures like joint debridement or replacement may be considered.
Clinical Advice & FAQs
Billing Guidance
Is M11.13 a billable ICD-10 code?
Yes, M11.13 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M11.13?
Clinical documentation must specify the nature of Familial chondrocalcinosis, wrist and any associated comorbidities for accurate reporting.
Cite this Clinical Reference